Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Seratrodast [USAN:INN]
RN: 112665-43-7
UNII: 4U58JM421N
InChIKey: ZBVKEHDGYSLCCC-UHFFFAOYSA-N

Note

  • Has thromboxane A2 & prostaglandin H2 receptor antagonistic action.

Molecular Formula

  • C22-H26-O4

Molecular Weight

  • 354.443
 

Classification Codes

  • Analgesics
  • Analgesics, Non-Narcotic
  • Anti-Asthmatic (Thromboxane Receptor Antagonist)
  • Anti-Asthmatic Agents
  • Anti-Inflammatory (Nonantihistaminic)
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Drug / Therapeutic Agent
  • Hormone Antagonists
  • Hormones, Hormone Substitutes, and Hormone Antagonists
  • Peripheral Nervous System Agents
  • Prostaglandin Antagonists
  • Reproductive Effect
  • Respiratory System Agents
  • Sensory System Agents
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Seratrodast
  • Seratrodast [USAN:INN]

Synonyms

  • (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid
  • A 73001
  • A-73001
  • AA-2414
  • Abbott 73001
  • Abbott-73001
  • ABT 001
  • ABT-001
  • CCRIS 8939
  • NSC 759640
  • Seratrodast
  • UNII-4U58JM421N

Systematic Names

  • (+-)-2,4,5-Trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic acid
  • Benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)-

Registry Numbers

CAS Registry Number

  • 112665-43-7

FDA UNII

  • 4U58JM421N

Other Registry Number

  • 103186-19-2

System Generated Number

  • 0112665437

Structure Descriptors

InChI

InChI=1S/C22H26O4/c1-14-15(2)22(26)20(16(3)21(14)25)18(17-10-6-4-7-11-17)12-8-5-9-13-19(23)24/h4,6-7,10-11,18H,5,8-9,12-13H2,1-3H3,(H,23,24)

InChIKey

ZBVKEHDGYSLCCC-UHFFFAOYSA-N

Smiles

CC1=C(C)C(=O)C(=C(C)C1=O)C(CCCCCC(=O)O)c2ccccc2

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
monkey LD oral > 2gm/kg (2000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 38, Pg. 394, 1996.
mouse LD50 intraperitoneal 1100mg/kg (1100mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
mouse LD50 oral 1520mg/kg (1520mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
mouse LD50 subcutaneous > 5gm/kg (5000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
rat LD50 intraperitoneal 1350mg/kg (1350mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
rat LD50 oral 3750mg/kg (3750mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
rat LD50 subcutaneous > 5gm/kg (5000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.